Literature DB >> 7641716

Comparison of tramadol with morphine for post-operative pain following abdominal surgery.

M D Vickers1, D Paravicini.   

Abstract

In a multi-centre, double-blind, randomized study involving 523 patients, the analgesic efficacy of tramadol was compared to that of morphine given in repeated intravenous boluses as required to control post-operative pain following abdominal surgery over 24 h. Intravenous administration of the study analgesic started as soon as the patient reported pain. Patients received an initial dose (either tramadol 100 mg or morphine 5 mg) and, if necessary, repeat doses of tramadol 50 mg or morphine 5 mg could be given on demand over the first 90 min. Further doses up to a total of tramadol 400 mg or morphine 40 mg could then be given after 90 min up to 24 h after the first dose of study medication. The primary efficacy parameter was the responder rate (no or slight pain) within the first 90 min of treatment. Whilst responder rates reached 72.6% with tramadol and 81.2% with morphine, the treatments were statistically equivalent and the observed difference in the responder rates between the groups was within the predefined range of +/- 10%. Mean cumulative doses received by treatment responders amounted to 188.2 mg within the first 1.5 h and 157.1 mg during the subsequent 22.5 h in the tramadol group and 13.9 and 18.4 mg, respectively, in the morphine group. A high incidence of gastrointestinal adverse events were observed with both treatments mostly consisting of mild nausea, dry mouth, vomiting, dyspepsia and hiccups.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7641716

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  17 in total

1.  PharmGKB summary: tramadol pathway.

Authors:  Li Gong; Ulrike M Stamer; Mladen V Tzvetkov; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-07       Impact factor: 2.089

2.  [Effectiveness and tolerance of tramadol in cancer pain. A comparative study with respect to buprenorphine].

Authors:  A V Bono; S Cuffari
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 3.  [Tramadol in acute pain].

Authors:  K A Lehmann
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 4.  [Tolerance and safety of tramadol use. Results of international studies and data from drug surveillance].

Authors:  M Cossmann; C Kohnen; R Langford; C McCartney
Journal:  Drugs       Date:  1997       Impact factor: 9.546

5.  Effect of tramadol and morphine on pain and gastrointestinal motor function in patients with chronic pancreatitis.

Authors:  C H Wilder-Smith; L Hill; W Osler; S O'Keefe
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

Review 6.  Clinical pharmacology of tramadol.

Authors:  Stefan Grond; Armin Sablotzki
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 7.  A risk-benefit assessment of tramadol in the management of pain.

Authors:  L Radbruch; S Grond; K A Lehmann
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

Review 8.  Tramadol: a review of its use in perioperative pain.

Authors:  L J Scott; C M Perry
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

9.  Ultra low-dose naloxone and tramadol/acetaminophen in elderly patients undergoing joint replacement surgery: a pilot study.

Authors:  Ngozi N Imasogie; Sudha Singh; James T Watson; Debbie Hurley; Patricia Morley-Forster
Journal:  Pain Res Manag       Date:  2009 Mar-Apr       Impact factor: 3.037

10.  Intraindividual differences in pain relief and functional improvement in osteoarthritis with diclofenac or tramadol.

Authors:  K Pavelka; Z Pelisková; H Stehlíková; S Ratcliffe; C Repas
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.